These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36889122)

  • 21. Altered Cortical and Hippocampal Excitability in TgF344-AD Rats Modeling Alzheimer's Disease Pathology.
    Stoiljkovic M; Kelley C; Stutz B; Horvath TL; Hajós M
    Cereb Cortex; 2019 Jun; 29(6):2716-2727. PubMed ID: 29920597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease.
    Kelly SC; He B; Perez SE; Ginsberg SD; Mufson EJ; Counts SE
    Acta Neuropathol Commun; 2017 Jan; 5(1):8. PubMed ID: 28109312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early ultrasonic vocalization deficits and related thyroarytenoid muscle pathology in the transgenic TgF344-AD rat model of Alzheimer's disease.
    Rudisch DM; Krasko MN; Barnett DGS; Mueller KD; Russell JA; Connor NP; Ciucci MR
    Front Behav Neurosci; 2023; 17():1294648. PubMed ID: 38322496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurodegeneration of Trigeminal Mesencephalic Neurons by the Tooth Loss Triggers the Progression of Alzheimer's Disease in 3×Tg-AD Model Mice.
    Goto T; Kuramoto E; Dhar A; Wang RP; Seki H; Iwai H; Yamanaka A; Matsumoto SE; Hara H; Michikawa M; Ohyagi Y; Leung WK; Chang RC
    J Alzheimers Dis; 2020; 76(4):1443-1459. PubMed ID: 32651317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer's disease.
    Matchett BJ; Grinberg LT; Theofilas P; Murray ME
    Acta Neuropathol; 2021 May; 141(5):631-650. PubMed ID: 33427939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's disease-like pathology-triggered oxidative stress, alterations in monoamines levels, and structural damage of locus coeruleus neurons are partially recovered by a mix of proteoglycans of embryonic genesis.
    Aghajanov M; Chavushyan V; Matinyan S; Danielyan M; Yenkoyan K
    Neurochem Int; 2019 Dec; 131():104531. PubMed ID: 31425747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections.
    Iba M; McBride JD; Guo JL; Zhang B; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2015 Sep; 130(3):349-62. PubMed ID: 26150341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatiotemporal characterization of cellular tau pathology in the human locus coeruleus-pericoerulear complex by three-dimensional imaging.
    Gilvesy A; Husen E; Magloczky Z; Mihaly O; Hortobágyi T; Kanatani S; Heinsen H; Renier N; Hökfelt T; Mulder J; Uhlen M; Kovacs GG; Adori C
    Acta Neuropathol; 2022 Oct; 144(4):651-676. PubMed ID: 36040521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Locus Coeruleus in Aging and Alzheimer's Disease: A Postmortem and Brain Imaging Review.
    Beardmore R; Hou R; Darekar A; Holmes C; Boche D
    J Alzheimers Dis; 2021; 83(1):5-22. PubMed ID: 34219717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered basal forebrain function during whole-brain network activity at pre- and early-plaque stages of Alzheimer's disease in TgF344-AD rats.
    van den Berg M; Adhikari MH; Verschuuren M; Pintelon I; Vasilkovska T; Van Audekerke J; Missault S; Heymans L; Ponsaerts P; De Vos WH; Van der Linden A; Keliris GA; Verhoye M
    Alzheimers Res Ther; 2022 Oct; 14(1):148. PubMed ID: 36217211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early neurovascular dysfunction in a transgenic rat model of Alzheimer's disease.
    Joo IL; Lai AY; Bazzigaluppi P; Koletar MM; Dorr A; Brown ME; Thomason LA; Sled JG; McLaurin J; Stefanovic B
    Sci Rep; 2017 Apr; 7():46427. PubMed ID: 28401931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurophysiological signals as predictive translational biomarkers for Alzheimer's disease treatment: effects of donepezil on neuronal network oscillations in TgF344-AD rats.
    Stoiljkovic M; Kelley C; Horvath TL; Hajós M
    Alzheimers Res Ther; 2018 Oct; 10(1):105. PubMed ID: 30301466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Waning locus coeruleus integrity precedes cortical tau accrual in preclinical autosomal dominant Alzheimer's disease.
    Jacobs HIL; Becker JA; Kwong K; Munera D; Ramirez-Gomez L; Engels-Domínguez N; Sanchez JS; Vila-Castelar C; Baena A; Sperling RA; Johnson KA; Lopera F; Quiroz YT
    Alzheimers Dement; 2023 Jan; 19(1):169-180. PubMed ID: 35298083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global neuropathologic severity of Alzheimer's disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels.
    Murray ME; Moloney CM; Kouri N; Syrjanen JA; Matchett BJ; Rothberg DM; Tranovich JF; Sirmans TNH; Wiste HJ; Boon BDC; Nguyen AT; Reichard RR; Dickson DW; Lowe VJ; Dage JL; Petersen RC; Jack CR; Knopman DS; Vemuri P; Graff-Radford J; Mielke MM
    Mol Neurodegener; 2022 Dec; 17(1):85. PubMed ID: 36575455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sparse Asymmetry in Locus Coeruleus Pathology in Alzheimer's Disease.
    Beckers E; Riphagen JM; Van Egroo M; Bennett DA; Jacobs HIL
    J Alzheimers Dis; 2024; 99(1):105-111. PubMed ID: 38607758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential Alzheimer's early biomarkers in a transgenic rat model and benefits of diazoxide/dibenzoylmethane co-treatment on spatial memory and AD-pathology.
    Wallace CH; Oliveros G; Xie L; Serrano P; Rockwell P; Figueiredo-Pereira M
    Sci Rep; 2024 Feb; 14(1):3730. PubMed ID: 38355687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (-)-P7C3-S243 Protects a Rat Model of Alzheimer's Disease From Neuropsychiatric Deficits and Neurodegeneration Without Altering Amyloid Deposition or Reactive Glia.
    Voorhees JR; Remy MT; Cintrón-Pérez CJ; El Rassi E; Khan MZ; Dutca LM; Yin TC; McDaniel LN; Williams NS; Brat DJ; Pieper AA
    Biol Psychiatry; 2018 Oct; 84(7):488-498. PubMed ID: 29246437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of intraneuronal amyloid beta oligomers in locus coeruleus neurons of Alzheimer's patients and their potential impact on inhibitory neurotransmitter receptors and neuronal excitability.
    Kelly L; Seifi M; Ma R; Mitchell SJ; Rudolph U; Viola KL; Klein WL; Lambert JJ; Swinny JD
    Neuropathol Appl Neurobiol; 2021 Jun; 47(4):488-505. PubMed ID: 33119191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer's disease.
    Cassidy CM; Therriault J; Pascoal TA; Cheung V; Savard M; Tuominen L; Chamoun M; McCall A; Celebi S; Lussier F; Massarweh G; Soucy JP; Weinshenker D; Tardif C; Ismail Z; Gauthier S; Rosa-Neto P
    Neuropsychopharmacology; 2022 Apr; 47(5):1128-1136. PubMed ID: 35177805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Locus coeruleus integrity is related to tau burden and memory loss in autosomal-dominant Alzheimer's disease.
    Dahl MJ; Mather M; Werkle-Bergner M; Kennedy BL; Guzman S; Hurth K; Miller CA; Qiao Y; Shi Y; Chui HC; Ringman JM
    Neurobiol Aging; 2022 Apr; 112():39-54. PubMed ID: 35045380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.